1. Home
  2. ALBT vs XXII Comparison

ALBT vs XXII Comparison

Compare ALBT & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$0.55

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$2.93

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALBT
XXII
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.3M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
ALBT
XXII
Price
$0.55
$2.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.2M
25.0K
Earning Date
05-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.96
EPS
N/A
N/A
Revenue
$1,333,403.00
$25,832,530.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$79.56
P/E Ratio
N/A
N/A
Revenue Growth
6.19
N/A
52 Week Low
$0.42
$0.67
52 Week High
$5.35
$11.37

Technical Indicators

Market Signals
Indicator
ALBT
XXII
Relative Strength Index (RSI) 41.33 31.65
Support Level $0.48 $1.52
Resistance Level $0.93 $6.86
Average True Range (ATR) 0.09 0.23
MACD -0.01 -0.07
Stochastic Oscillator 16.57 0.79

Price Performance

Historical Comparison
ALBT
XXII

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: